A Primary Care Intervention for Weight Management
Study Details
Study Description
Brief Summary
The study will test whether adding brief counseling visits with an ancillary health care provider (a nurse or nursing assistant) will induce additional weight loss, as compared with quarterly physician visits alone. All visits will take place at the site of usual patient care (i.e., the primary care clinic).
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 3 |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| No Intervention: 1 Control group, receives physician advice for weight loss and materials |
|
| Active Comparator: 2 Active treatment group, receives physician advice, materials, and brief weight loss counseling |
Behavioral: Weight loss counseling
A comparison of weight loss advice provided by primary care physicians to advice plus brief weight loss counseling provided by medical assistants. Participants in both groups receive weight loss materials.
|
Outcome Measures
Primary Outcome Measures
- Weight change [6 months]
Secondary Outcome Measures
- Blood pressure [6, and 12 months]
- Lipids [6, and 12 months]
- Fasting glucose [6, and 12 months]
- Quality of life [6, and 12 months]
- Weight change [12 months]
- Waist circumference [6 and 12 months]
Eligibility Criteria
Criteria
Inclusion Criteria:
Body mass index (BMI) of 27 to 50 kg/m2 Capacity to provide informed consent Ability to find transportation to and from counseling sessions Willingness to be randomized to either program Commitment to attend all sessions and to complete study-related assessments, including blood tests and questionnaires
Exclusion Criteria:
Type I diabetes Myocardial infarction or stroke within the previous 6 months Clinically significant renal or hepatic disease (as judged by a study physician) History of cancer in the past 5 years Congestive heart failure requiring diuretics Previous weight loss surgery Endocrine conditions that may cause weight gain, including unstable thyroid disease or hypercortisolism Initiation of therapy with or dose change to any of the following medications within 6 weeks of starting the study: insulin; metformin; sulfonylurea; thiazolidinedione; HMG-CoA reductase inhibitor ("statin"); or SSRI for depression Long-term use of any of the following medications: oral or high-dose inhaled steroid; atypical antipsychotic; tricyclic antidepressant; antiepileptic; any prescription or over-the-counter drug for weight loss Systolic blood pressure > 160 or diastolic blood pressure > 100 Hemoglobin A1c ≥ 10 Pregnancy or lactation Clinically significant psychiatric disease, including major depression, eating disorders, or substance abuse
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Edward S. Cooper Internal Medicine Practice | Philadelphia | Pennsylvania | United States | 19104 |
| 2 | Presbyterian Medical Group | Philadelphia | Pennsylvania | United States | 19104 |
Sponsors and Collaborators
- Kaiser Permanente
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Investigators
- Principal Investigator: Thomas A Wadden, PhD, Director, Weight and Eating Disorders Program, University of Pennsylvania
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NCT00271193
- K24DK065018